- A novel ultrasonic bone quality biomarker was tested in a population with low to high exposure to F.–
- Negative associations were found between F– exposure and bone quality
- Decreased bone quality reflects net bone loss, abnormal mineralization and altered collagen.
- The finding highlights that F– exposure has complex effects on bone quality that go beyond changes in bone density alone.
Background: Various studies, mostly with animals, have provided evidence of adverse impacts of fluoride (F–) on bone density, collagen and microstructure, yet its effects on overall bone quality (strength) has not been clearly or extensively characterized in human populations.
Objective: In this observational study, we assessed variation in an integrated measures of bone quality in a population exposed to wide-ranging F– levels (0.3 to 15.5 mg/L) in drinking water, using a novel application of non-ionizing ultrasonic method.
Method: We collected 871 speed of sound (SOS) measurements from 341 subjects residing in 25 communities, aged 10-70 years (188 males and 153 females). All subjects received scans of the cortical radius and tibia, and adults over the age of 19 received an additional scan of the phalanx. Associations between F– in drinking water and 24-h urine samples, and SOS as a measure of bone quality, were evaluated in bivariate and multivariable regressions adjusting for age, sex, BMI, smoking, and toothpaste use.
Results: We found negative associations between F– exposure and bone quality at all three bones. Adult tibial SOS showed the strongest inverse association with F– exposure, which accounted for 20% of the variance in SOS measures (r = 0.45; n = 199; p < 0.0001). In adjusted analysis, a 1 mg/L increase in F– in drinking water was related to a reduction of 15.8 m/s (95% CI: -21.3 to -10.3), whereas a 1 mg/L increase in 24-h urinary F– (range: 0.04-39.5 mg/L) was linked to a reduction of 8.4 m/s (95% CI: -12.7, -4.12) of adult tibial SOS. Among adolescents, in contrast, weaker and non-significant inverse associations between F– exposure and SOS were found, while age, gender, and BMI were more significant predictors than in adults.
Conclusions: These results are indicative of a fluoride-induced deterioration of bone quality in humans, likely reflecting a combination of factors related to SOS: net bone loss, abnormal mineralization and collagen formation, or altered microarchitecture. The portable and low-cost ultrasound technique appears potentially useful for assessment of bone quality, and should be tested in other locations and for other bone-related disorders, to assess the feasibility of its more extensive diagnostic use in hard-to-reach rural regions.
BMI, Body Mass Index; Bone biomarker; Bone quality; Ethiopian Rift Valley; F-, qFluoride; Fluoride exposure; IRB, Institutional Review Board; ISE, Ion Selective Electrode; MER, Main Ethiopian Rift; NOAEL, No-Observed-Adverse-Effects-Level; Quantitative ultrasound; SOS, Speed of Sound; Speed of sound; TISAB, Total Ionic Strength Adjuster Buffer; U.S. EPA, U.S. Environmental Protection Agency; U.S. NRC, U.S. National Research Institute; WHO, World Health Organization; bw, body weight; mg/L, milligram per liter; mg/kg bw/day, milligram per kilogram body weight per day
Effect of ultrastructural changes on the toughness of bone.
The ultrastructure of bone can be considered as a conjunction between the biology and the biomechanics of the tissue. It is the result of cellular and molecular activities of bone formation, and its organization dominates the mechanical behavior of bone. Following this perspective, the objective of this review is to
Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial
INTRODUCTION: Treatment of osteoporosis with high-dose fluoride alone does not reduce fracture risk. We hypothesized that the antifracture efficacy of fluoride could be optimized by its use in low doses combined with an antiresorptive agent. EXPERIMENTAL SUBJECTS: Subjects included 80 women with postmenopausal osteoporosis who had been taking estrogen for at least 1
Toxic effect of fluoride on biochemical parameters and collagen metabolism in osseous and non-osseous tissues of rats
The present study was carried out to assess the effects of fluoride exposure on collagen metabolism by evaluating the level of hydroxyproline in both osseous and non-osseous tissues along with serum biochemical parameters in rats. Eight week old female rats were divided into two equal groups of six rats each.
Effects of fluorine on calcium metabolism and bone growth in pigs
Summary The interrelated effects of dietary fluorine and feed intake on bone growth, body growth, Ca45 behavior, bone pathology and feed utilization are demonstrated in young pigs. A fluorine level of 1000 ppm in the ration reduced the appetite and caused a decrease in bone growth, body growth, and feed required per
Bone resorption and quantitative ultrasound in an endemic fluorosis area of Turkey.
The purpose of this prospective study was to investigate the quantity and quality of bone by quantitative ultrasound (QUS) measurements and to assess bone resorption by urinary excretion measurement of C-terminal telopeptide of type I collagen (CTX) in an adult Turkish population living in an endemic fluorosis area and consuming
Related Studies :
Fluoride & Osteoarthritis
While the osteoarthritic effects that occurred from fluoride exposure were once considered to be limited to those with skeletal fluorosis, recent research shows that fluoride can cause osteoarthritis in the absence of traditionally defined fluorosis. Conventional methods used for detecting skeletal fluorosis, therefore, will fail to detect the full range of people suffering from fluoride-induced osteoarthritis.
As demonstrated by the studies below, skeletal fluorosis may produce adverse symptoms, including arthritic pains, clinical osteoarthritis, gastrointestinal disturbances, and bone fragility, before the classic bone change of fluorosis (i.e., osteosclerosis in the spine and pelvis) is detectable by x-ray. Relying on x-rays, therefore, to diagnosis skeletal fluorosis will invariably fail to protect those individuals who are suffering from the pre-skeletal phase of the disease. Moreover, some individuals with clinical skeletal fluorosis will not develop an increase in bone density, let alone osteosclerosis, of the spine. Thus, relying on unusual increases in spinal bone density will under-detect the rate of skeletal fluoride poisoning in a population.
Skeletal Fluorosis: The Misdiagnosis Problem
It is a virtual certainty that there are individuals in the general population unknowingly suffering from some form of skeletal fluorosis as a result of a doctor's failure to consider fluoride as a cause of their symptoms. Proof that this is the case can be found in the following case reports of skeletal fluorosis written by doctors in the U.S. and other western countries. As can be seen, a consistent feature of these reports is that fluorosis patients--even those with crippling skeletal fluorosis--are misdiagnosed for years by multiple teams of doctors who routinely fail to consider fluoride as a possible cause of their disease.
Related FAN Content :